Prelude Capital Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,985
| Closed | -$86K | – | 1160 |
|
|
2024
Q3 | $86K | Sell |
15,985
-16,971
| -51% | -$91.3K | 0.01% | 1064 |
|
|
2024
Q2 | $110K | Sell |
32,956
-15,644
| -32% | -$52.4K | 0.01% | 995 |
|
|
2024
Q1 | $196K | Hold |
48,600
| – | – | 0.01% | 1009 |
|
|
2023
Q4 | $129K | Buy |
48,600
+15,200
| +46% | +$40.3K | 0.01% | 875 |
|
|
2023
Q3 | $78.8K | Buy |
+33,400
| New | +$78.8K | 0.01% | 871 |
|